Whalegun
Home

Alnylam Pharmaceuticals ALNY paid Tiber Creek Group $60K for lobbying in Q1 2025 · Medicare

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q1 2025
Stock
Alnylam Pharmaceuticals ALNY
Client
Alnylam Pharmaceuticals
Reported
25/04/18

Up 0.0% from last quarter

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Alnylam Pharmaceuticals's other lobbying reports